Form 4: Arcutis Biotherapeutics Executive Sells Shares
Insider Transaction (Form 4)
Patrick Burnett, See Remarks of Arcutis Biotherapeutics, Inc., sold 955 shares of common stock on August 3, 2026 for $26.12 per share.
Summary
- Open-market sale: disposed of 955 Common Stock at $26.12 ($24,942) on August 3, 2026; holds 119,289 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $24,942 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Patrick Burnett — Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Open-market sale | Common Stock | 955 | $26 | $24.9K | 119,289 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Open-market sale (955 shares) |
Keywords
insider transaction, Form 4, ARQT, Arcutis Biotherapeutics, Inc., bearish, Patrick Burnett
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.